Alfresa Holdings Corporation (ALFRY)

Market Cap	3.03B +20.9%
Revenue (ttm)	19.53B +4.1%
Net Income	214.58M -2.2%
EPS	1.18 +0.3%
Shares Out	n/a
PE Ratio	14.10
Forward PE	n/a
Dividend	0.45 (2.76%)
Ex-Dividend Date	Mar 30, 2026

Volume	316
Average Volume	1,916
Open	16.22
Previous Close	n/a
Day's Range	16.22 - 16.36
52-Week Range	11.39 - 16.36
Beta	-0.27
RSI	n/a
Earnings Date	Feb 10, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALFRY

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial numbers in JPY